PLOD Family: A Novel Biomarker for Prognosis and Personalized Treatment in Soft Tissue Sarcoma

Despite various treatment attempts, the heterogenous group of soft tissue sarcomata (STS) with more than 100 subtypes still shows poor outcomes. Therefore, effective biomarkers for prognosis prediction and personalized treatment are of high importance. The Procollagen-Lysine, 2-Oxoglutarate 5-Dioxyg...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Siming, Schopow, Nikolas, Duan, Yingjuan, Wu, Changwu, Kallendrusch, Sonja, Osterhoff, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141206/
https://www.ncbi.nlm.nih.gov/pubmed/35627171
http://dx.doi.org/10.3390/genes13050787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141206/
https://www.ncbi.nlm.nih.gov/pubmed/35627171
http://dx.doi.org/10.3390/genes13050787

Ejemplares similares